Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03476837 · ClinicalTrials.gov registry record · NA

Reducing Tobacco Exposures Among African American Women and Children

A NA study, sponsored by University of Arkansas.

Completed
Registry status
NA
Development phase
200
Enrollment target

NCT03476837 is a NA study that has completed, run by University of Arkansas. The registered enrollment target is 200 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03476837, a NA study, has completed, sponsored by University of Arkansas.

COMPLETED
Registry status
NA
Development phase
200 participants
Enrollment target

Study Summary

Secondhand smoke exposure in the home can causes sudden infant death syndrome (SIDS), asthma, respiratory illnesses, and ear infections in children. In addition to cigarette smoke, exposure to other tobacco products can further compromise the safety of children in the home. This study aims to reduce the burden of multiple tobacco exposures, improve access to preventive care, and reduce the disproportionate risk for chronic diseases, including cancer, among African American women and children living in the Arkansas Delta region. Our central hypothesis is that messages delivered by a community health worker that aim to modify knowledge, attitudes, beliefs, and subjective norms may influence the perceived threat of tobacco exposures and provide cues for African American women caregivers to implement comprehensive smokefree policies to protect their children from the harms of tobacco and in-turn, influence their quitting.

Interventions

  • BEHAVIORAL Control
  • BEHAVIORAL Treatment

Trial Details

FieldValue
Enrollment Target 200 participants
Start Date 2020-01-15
Est. Completion 2023-06-30
Phase NA

Sponsor

University of Arkansas

318 total trials

What the Registry Record Tells You About NCT03476837

The ClinicalTrials.gov registry entry for NCT03476837 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Arkansas, which has 318 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Control is the first listed.

NCT03476837 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03476837 about?

NCT03476837 is a clinical study titled "Reducing Tobacco Exposures Among African American Women and Children". Secondhand smoke exposure in the home can causes sudden infant death syndrome (SIDS), asthma, respiratory illnesses, and ear infections in children. In addition to cigarette smoke, exposure to other tobacco products can further compromise the safety of children in the home. This study aims to reduce...

What is the current status of trial NCT03476837?

This trial is currently completed. It is a NA study. The enrollment target is 200 participants. The study started on 2020-01-15. Estimated completion is 2023-06-30.

What interventions are being tested in trial NCT03476837?

The interventions under investigation include: Control (BEHAVIORAL), Treatment (BEHAVIORAL).

Who is sponsoring clinical trial NCT03476837?

This trial is sponsored by University of Arkansas, which has 318 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.